At risk of admonishment, I respectfully inquire if it is fair to ask the company to immediately report 1st patient dosing, at least within a day or so?

Correct me if I'm wrong, but did the CEO say the company expects to "have 1st patient dosed by end of July" or update the market by end of July?

If the former, then I would hope the patient has in fact received an initial dose of Ifenprodil and the company, especially if happened Thursday or Friday, will have an update by early next week. In my opinion.

If I've misunderstood the company's statement, I apologize.

Please, AMG, commense my education.

Your blunt commentary is very much appreciated.

Missing footnote..

I never bought the sister..lol

Yep I have many horror stories to tell in the 3 short years of sloshing around the sewers of the stock market, also known as the OTC...LOL

The endless hot sideways action around here reminded me of past beatings, which lead to, or at least that's what I've tricked myself to believe, this story of OTC failure.

I noticed during lunch one day that PAOG had moved from .0007 to .0012. After nearly spitting out my food, I quickly, and without hesitation, sold 80% of my holdings.

No need to tell you how that move ended up.

The story has an even uglier end, however.

My plan was to put the salvaged funds into the former sister, which sat somewhere in the .0011 range, I believe. Sorry if I'm a little off on those #'s, it's painful to regurgitate.

Again... no need to tell you how that one ended up.

Anyway.. my last 20% looking Boomy around here!

...will most likely sell before a huge run.

Is this the gang from another ticker that was supposed to go "Boom"?

I remember only a bunch of "hot, sideways action" goin on over there.

I remain a bagholder... but you and Greasy gave me some good laughs from time time time.

I thank you for that.

WTF happened here? Stopped trading at .0018? Thought it would at least go to .0001, like the majority of my OTC plays.

Ahh, the sewers of the stock market.. gotta love it.

I understand your frustration. Sorry I'm not aware of your "date of entry" into this. Maybe you have an origin story of your own. Could probably start a support group.

My nightmarish journey, up until 2 months ago, with BTHCF/AGNPF has been a humbling realization if my lack of self control. I told myself throughout that long descent into share price darkness, this past winter especially, that if I ever get even again, I'm out. And I live in MN where it's cold. Bone chilling, die of exposure in 10min type of cold. AGNPF under .10 and falling made it feel even colder.

And this was after a reverse-split which brought my .13 average to .26 overnight.

Add to this equation 1 name... Kal Malhi.

...Run.

After the COVID-19 potential drove us near .50 I could have bailed with a substantial profit, much more then the break-even point I had in mind when the SP sat around. 04.

Anyway, haven't sold a single share and don't plan on it until I find out if Ifenprodil can fulfill 1, if not all, of it's many different treatment angles.

So, the point of my stumbling story... regardless of the many "red flags" and bad omens that surround this company and ownership group, I'm all-in, no matter what I try to tell myself.

Hopelessly devoted.

Agree Danny D.

I can't see how any "share price moving" updates will result from the BioPub interview. Any news of significance will be a carefully worded, early morning (hopefully soon) press release, not some off the cuff commentary during an interview.

Also, I don't believe SK data will come until mid June anyway (28 day study?), so Monday is not "make or break", IMO. Without data it won't matter what they say.

I'm sure they won't come back to Biopub with the same status as last time, so I do expect to hear something of significance, but nothing other then data will move the share price.

More time to accumulate.

LS5 2 penny's worth.

PS... AMG "The Wordsmith" replied to a previous comment of mine (a bucket list worthy moment btw) and addressed me as LS5... I think I'll keep it.

That'll be distant memory once news of data is released.
Well, positive data anyway. But yea, could be the source for future nightmares if not positive. Lol
If we get a pop in share price again that is unrelated to data, then I suggest selling into it as anything short of positive findings will surely send it back down within days, or 15 minutes, like the last time.
I'm here to see the results, good or bad. My confidence lies in facts. Positive results for CC in animal testing tells me this drug can treat CC, just need it to work in humans which involves side effects and safety, which has been determined long ago as the drug has been around since 1971.
The COVID-19 angle is intriguing but had no involvement in my initial investment.

The Return of the King!

See what happens when you take a few days off?
...sorry, no disrespect intended, only an attempt at referencing how quickly this board descended into wild "fake company" theory chaos.
As always, you've provided unbiased, knowledgeable insight from the perspective of someone who has been around since inception. My only reason for not bailing after the reverse-split was your breakdown of the repurposed drug business model.
The whole share structure issues elude my level of understanding, but if I've learned anything over the years creeping around on this board, it's to beware of Bull Run Capital!
My investment remains in my belief in the company's CEO and CSO.
Cruel timing with the PP.. but it did allow me an opportunity to add more shares.
The safety history of Ifenprodil increasing the 50/50 odds of Phase II success has my confidence level high. High enough to laugh at the noise that has recently infested this board.
The information you provided today about Dr. Williams previous success was something I was unaware of, and only increases the previously stated "Phase II odds".
Thank you for also providing us a reminder that COVID-19 isn't the only "iron in the fire" as Bellus gives us a near-perfect comparison of what the CC study alone could do for company valuation.

Thanks for sharing Smoki.
For all the doom and gloom on here, that is very encouraging, or should be, imo.
Third party validation that proves we are right in the thick of it.
Nothing has changed except for keeping the door open to acquiring discounted tickets for the ride.
I remain unwavered in my confidence in our CEO and CSO.

I have no answers to you questions. I can only speak to my own actions.
Every concern you raise is valid and I dispute none of it. They (ownership and management) have me at this crossroads moment of "good cop, bad cop" and which one is calling the shots. For a while there I almost forgot about Kal and the gang, as if Chris and Mark were running this show. Now the circus is back in town and we've all been snapped back to reality.
At this point, I, along with everyone else that's in a long position here or at BLOZF, should know better by now to expect anything less from this band of thieves.
I lost half of my shares after the split, somehow made it back to and surpassed breakeven when it went .40+ momentarily, and I still haven't sold out.
Can't sell.
There is no way, having gone through all of this, to sell and not find out if this drug works.
Too close to finally seeing human trial data.
Pot committed.

Company shenanigans over the years have always revolved around outstanding potential with indeterminate timelines.
They have teased us with the potential while fleecing us in the long, long run up to greatness.
I'm not saying it doesn't frustrate me, but the sister (now somewhat estranged) had the same mistrust as we do here and now. Anyone remember the empty black box? Lol. Anyway, with deception all around, we were still able to see $2.95/share before the wheels came off.
The point I'm so clumsily trying to make is that we are on the brink of knowing exactly what we have and what kind of impact Ifenprodil can have on CC, IPF and COVID-19. Management is why I am here, the CEO and CSO have worked tirelessly to get us here, surpassing timelines and expectations along the way. Ok, so now we hit a bump in the road, I'm not ready to bail on them yet.
The owner's (Kal, "friends &family") are
running out of time to play their "trader games", in my clumsy opinion.

I believe with 100k shares you need to quit looking at boats and order a customized yacht. "The XJ".
I'm catching up Jagger! Well, kind of anyway, 25k and hoping to add another 10 this week!
And there was no BS implied with my previous comment!
The only thing I believe you have wrong is the target of "30 dolla".
If CC and IPF are both billion $ markets, a treatment for COVID-19 will be 10X that, at least.
See you in Viva Las Vegas! My soon to be friend.

Thanks for showing up! I needed some help keeping this share price down for another week. I just found out my stimulus money will be deposited on the 15th.
Algernon will turn it into a little extra partying funds in Vegas with Jagger and the boys.
Hell, hit me up when it's bought out namah, I got you for the Vegas trip.

Take away the recent PP and we are still right in the middle of a solution putting an $80 trillion economy back to work.
I understand the skepticism, it's been much earned with the Bullrun crew, but there are also valid reasons for the fund raising. A non-revenue earning company hasn't many options.
I invested in the 4 drugs in the pipeline reaching Phase II Clinical trials and have been looking forward to the lead candidate NP-120 getting to the point of dosing patients. In case anyone has forgotten, we are on the cusp of these trials in Australia. That alone is all my original investment entailed to accomplish at this time. When we add the COVID-19 angle, it became a giant cherry on top.
We all need a treatment for COVID-19, whether it is Ifenprodil or something else. But as I'm sure we can all see for ourselves the field has narrowed greatly with the complete failure of Chloroquine and the less than spectacular results of Remdesivir. That leaves us with as good a chance to have the 1st valid treatment as anyone at this point.
A known safety history is a huge factor in this race, imo. The efficacy is, of course, paramount but we have eliminated the potential safety issues that plagued Chloroquine. We also have a drug that can be taken in the early stages of the viral infection in pill form and the more serious stage with the injection. Remdesivir loses it's luster when considering the fact that, as an antiviral, it doesnt work as well once the virus has spread to the point of hospitalization. It's ideal use as an early stage treatment becomes moot when it can only be given through an IV drip.
Looong story short, I'm here for the results of the trials. It wouldn't matter if the share price was double or even triple from this level, I'm not selling anyway. We are right where we want to be, and light years from where we were when Breathtec became Algernon.
This doubt and skepticism is only leaving the door open for me to get to Jaggers 100,000 retirement level. Lol
30. Bagger... Easy.